Two Sigma Securities, LLC Vbi Vaccines Inc Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $46,155 - $61,320	-16,484 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $12,684 - $20,266	4,860 Added 41.81%	16,484 $55,000
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $33,825 - $50,215	11,624 New	11,624 $36,000
Q2 2020 Aug 14, 2020	SELL	$0.87 - $3.13 $17,695 - $63,664	-20,340 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.73 - $1.91 $14,848 - $38,849	20,340 New	20,340 $19,000
Q4 2019 Feb 14, 2020	SELL	$0.48 - $1.38 $16,325 - $46,936	-34,012 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.47 - $1.05 $8,474 - $18,931	18,030 Added 112.81%	34,012 $16,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $10,388 - $33,881	15,982 New	15,982 $19,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.